LC-MS application for therapeutic drug monitoring in alternative matrices

V Avataneo, A D'Avolio, J Cusato, M Cantù… - … of pharmaceutical and …, 2019 - Elsevier
Nowadays the practice of therapeutic drug monitoring, consisting in the measurement of
drugs concentrations in biological matrices in order to guide possible posological …

Matrix effect management in liquid chromatography mass spectrometry: the internal standard normalized matrix effect

A De Nicolò, M Cantù, A D'Avolio - Bioanalysis, 2017 - Taylor & Francis
LC–MS is becoming a standard for many applications, thanks to high sensitivity and
selectivity; nevertheless, some issues are still present, particularly due to matrix effect (ME) …

Automation of mass spectrometric detection of analytes and related workflows: A review

DP Elpa, GRD Prabhu, SP Wu, KS Tay, PL Urban - Talanta, 2020 - Elsevier
The developments in mass spectrometry (MS) in the past few decades reveal the power and
versatility of this technology. MS methods are utilized in routine analyses as well as research …

Barriers and opportunities for the clinical implementation of therapeutic drug monitoring in oncology

BD Menz, SL Stocker, N Verougstraete… - British Journal of …, 2021 - Wiley Online Library
There are few fields of medicine in which the individualisation of medicines is more
important than in the area of oncology. Under‐dosing can have significant ramifications due …

Modern automated microextraction procedures for bioanalytical, environmental, and food analyses

DM Sartore, DA Vargas Medina… - Journal of …, 2023 - Wiley Online Library
Sample preparation frequently is considered the most critical stage of the analytical
workflow. It affects the analytical throughput and costs; moreover, it is the primary source of …

Pharmacogenetic—Whole blood and intracellular pharmacokinetic—Pharmacodynamic (PG-PK2-PD) relationship of tacrolimus in liver transplant recipients

C Tron, JB Woillard, P Houssel-Debry, V David… - PLoS …, 2020 - journals.plos.org
Tacrolimus (TAC) is the cornerstone of immunosuppressive therapy in liver transplantation.
This study aimed at elucidating the interplay between pharmacogenetic determinants of TAC …

Measuring intracellular concentrations of calcineurin inhibitors: expert consensus from the international association of therapeutic drug monitoring and clinical …

F Lemaitre, NT Vethe, A d'Avolio, C Tron… - Therapeutic drug …, 2020 - journals.lww.com
Background: Therapeutic drug monitoring (TDM) of the 2 calcineurin inhibitors (CNIs),
tacrolimus (TAC) and cyclosporin A, has resulted in improvements in the management of …

[HTML][HTML] Monitoring intracellular tacrolimus concentrations and its relationship with rejection in the early phase after renal transplantation

MI Francke, LM Andrews, HL Le, D van de Velde… - Clinical …, 2022 - Elsevier
Introduction After kidney transplantation, rejection and drug-related toxicity occur despite
tacrolimus whole-blood pre-dose concentrations ([Tac] blood) being within the target range …

Monitoring the tacrolimus concentration in peripheral blood mononuclear cells of kidney transplant recipients

MI Francke, DA Hesselink, Y Li… - British Journal of …, 2021 - Wiley Online Library
Aims Tacrolimus is a critical dose drug and to avoid under‐and overexposure, therapeutic
drug monitoring is standard practice. However, rejection and drug‐related toxicity occur …

Longitudinal study of tacrolimus in lymphocytes during the first year after kidney transplantation

RA Klaasen, S Bergan, S Bremer, L Daleq… - Therapeutic Drug …, 2018 - journals.lww.com
Methods: PBMCs were isolated from whole blood by gradient centrifugation. After methanol-
based extraction, liquid chromatography with tandem mass spectrometry was used to …